Showing 531-540 of 690 results for "".
Lupus erythematosus tumidus vs Jessner's lymphocytic infiltrate of the Skin
https://practicaldermatology.com/topics/general-topics/lupus-erythematosus-tumidus-vs-jessners-lymphocytic-infiltrate-of-the-skin/21686/A systematic comparison of clinical and histologic characteristics.Setting Things Right
https://practicaldermatology.com/issues/supplements/setting-things-right/23412/Understanding the Role of Balneotherapy in Treating Moderate to Severe Atopic DermatitisRecent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-14/23289/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-10/23206/A.G.E. Interrupter Advanced: Newest Innovative Anti-Aging Cream
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/age-interrupter-advanced-newest-innovative-anti-aging-cream/23930/Treatment Guidelines for the PicoWay® Laser System in Skin of Color
https://practicaldermatology.com/topics/general-topics/treatment-guidelines-for-the-picoway-laser-system-in-skin-of-color/22087/Picosecond laser therapy for benign pigmented lesionsTetracyclines: History and Current Formulation Review From a Dermatology Perspective
https://practicaldermatology.com/topics/general-topics/tetracyclines-history-and-current-formulation-review-from-a-dermatology-perspective/21233/Atopic Dermatitis: A Review of Common Comorbidities
https://practicaldermatology.com/topics/atopic-dermatitis/atopic-dermatitis-a-review-of-common-comorbidities/23352/It is important to acknowledge and identify comorbidities to successfully manage AD and improve patient quality of life.Assessment of Superficially-placed Microaliquots of Small-particle HA
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/assessment-of-superficially-placed-microaliquots-of-small-particle-ha/23611/A prospective, open-label clinical trial assesses micro-injections of transparent hyaluronic acid gel for cheek rejuvenation.Cutaneous T-Cell Lymphoma: Mogamulizumab as a Novel Treatment for Refractory Mycosis Fungoides and Sezary Syndrome
https://practicaldermatology.com/youngmd-connect/resident-resource-center/Cutaneous-T-Cell-Lymphoma-Mogamulizumab-as-a-Novel-Treatment-for-Refractory-Mycosis-Fungoides-and-Sezary-Syndrome/23409/An overview of the diagnosis and prognosis of CTCL.